B.Riley Downgrades Mirati Therapeutics (MRTX) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. SPY
6. MRK
7. HD
8. DVLT
9. MRCY
10. LOW

October 9, 2023 6:48 AM EDT
Get Alerts MRTX Hot Sheet
Price: $58.70 --0%

Rating Summary:
    8 Buy, 18 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE

B.Riley analyst Kalpit Patel downgraded Mirati Therapeutics (NASDAQ: MRTX) from Buy to Neutral with a price target of $60.00 (from $65.00).


For an analyst ratings summary and ratings history on Mirati Therapeutics click here. For more ratings news on Mirati Therapeutics click here.


Shares of Mirati Therapeutics closed at $60.20 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades